+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Long-term effects of a slow release somatostatin analogue on hepatic venous pressure gradient in patients with proven esophageal varices



Long-term effects of a slow release somatostatin analogue on hepatic venous pressure gradient in patients with proven esophageal varices



Hepatology 36(4 Part 2): 509A




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 035235759

Download citation: RISBibTeXText


Related references

Long-time effects of a slow release somatostatin analogue on hepatic venous pressure gradient in patients with proven esophageal varices. Journal of Hepatology 38(Supplement 2): 60-61, 2003

Comparison of hepatic venous pressure gradient and endoscopic grading of esophageal varices. World Journal of Gastroenterology 22(11): 3212-3219, 2017

Portal pressure gradient reduction after long-term K-canrenoate in postviral child A cirrhosis with small esophageal varices Lack of sympathoinhibitory effects. Journal of Hepatology 40(Suppl 1): 72, 2004

Clinical trial: The effect of somatostatin vs. octreotide in preventing post-endoscopic increase in hepatic venous pressure gradient in cirrhotics with bleeding varices. Alimentary Pharmacology and Therapeutics 26(11-12): 1479-1487, 2007

Long-term treatment of acromegaly with the slow-release somatostatin analogue lanreotide. European Journal of Endocrinology 131(1): 20-26, 1994

Hepatic Venous Pressure Gradient Predicts Long-Term Mortality in Patients with Decompensated Cirrhosis. Yonsei Medical Journal 57(1): 138-145, 2016

Portal hypertensive gastropathy and gastric antral vascular ectasia in cirrhosis Relationships with hepatic venous pressure gradient, esophageal varices, and liver function. Hepatology 28(4 PART 2): 657A, 1998

Type 1 and 2 gastric carcinoid tumors: long-term follow-up of the efficacy of treatment with a slow-release somatostatin analogue. European Journal of Gastroenterology and Hepatology 19(11): 1021-1025, 2007

Measurement of wedged hepatic venous pressure accurately reflect the effects of vasoactive drugs on the pressure of the esophageal varices in alcoholic cirrhosis. Hepatology 6(5): 1190, 1986

Correlation of hepatic venous pressure gradient with variceal bleeding, size of esophageal varices, etiology, ascites and degree of liver dysfunction in cirrhosis of liver. Indian Journal of Gastroenterology 28(2): 59-61, 2010

Effects of surgical treatment of esophageal varices on the portal venous pressure and hepatic function: preliminary observations. Gastroenterology 24(1): 10-15, 1953

Relationships between the time-course of hepatic venous pressure gradient and the response to endoscopic treatment of varices in cirrhotic patients with acute variceal bleeding. Hepatology 34(4 Pt 2): 535A, 2001

Effects of splenectomy, devascularization and esophageal transection on portal venous pressure and portal perfusion in cirrhotic patients with bleeding esophageal varices. Journal of the Formosan Medical Association 92(10): 871-875, 1993

Short- and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis. Annals of Surgical Oncology 15(6): 1670-1676, 2008

The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly. Clinical Endocrinology 45(4): 415-421, 1996